- Investing Ideas
- /
- Australian Healthcare Undervalued Stocks Based On Cash Flows
Australian Healthcare Undervalued Stocks Based On Cash Flows
Results
3
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
Nanosonics
Market Cap: AU$1.3b
Operates as an infection prevention company globally.
NAN
AU$4.37
7D
0.2%
1Y
54.4%
Integral Diagnostics
Market Cap: AU$863.5m
A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand.
IDX
AU$2.29
7D
-5.4%
1Y
-2.1%
PolyNovo
Market Cap: AU$905.0m
Designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally.
PNV
AU$1.35
7D
6.3%
1Y
-40.0%